Impact of the COVID-19 pandemic on patients diagnosed with Fibromyalgia at the Rheumatology outpatient clinics in Aracaju, SE
DOI:
https://doi.org/10.33448/rsd-v12i5.41490Keywords:
COVID-19; Fibromyalgia; Quality of life.Abstract
The new COVID-19, first reported in China in December 2019, was declared a public health emergency of international concern in January 2020 by the World Health Organization (WHO). The consequences of this pandemic have had a significant impact on individuals' daily routines, negatively affecting patients with chronic pain. Fibromyalgia (FM) is a chronic condition characterized by widespread pain, fatigue, sleep disturbances, and cognitive changes. Its prevalence is estimated at 2.5% in Brazil, being more common in women. Demographic, socioeconomic, and psychosocial factors have been associated with greater pain intensity and interference during social distancing in these patients. This impact is related to the closure of clinics and physical activity spaces, healthcare professionals being diverted to COVID related activities, increasing wait times for consultations, delays in timely access to medications due to reduced prescription, reduced visits to physiotherapists, psychologists, and self-help groups, and the closure of group activity programs such as gyms, which previously facilitated social interaction, contributing to decrease quality of life (QL). The objective of this study was to evaluate the impact of these factors on the QL and pain of fibromyalgia patients during a pandemic. To this end, patients with fibromyalgia from three clinics in Aracaju-SE were interviewed using questionnaires. The data from this study suggest an association between pandemic lockdown and worsening symptoms, as well as the QL of patients living with this disease, especially when evaluated pain, mood, and sleep. Treatment interruption during this period and the presence of other associated comorbidities worsened the health condition.
References
Andrés-Rodríguez, L., Borràs, X., Feliu-Soler, A., Pérez-Aranda, A., Rozadilla-Sacanell, A., Arranz, B., Montero-Marin, J., García-Campayo, J., Angarita-Osorio, N., Maes, M., & Luciano, J. V. (2019). Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia. International journal of molecular sciences, 20(17), 4231. https://doi.org/10.3390/ijms20174231
Batres-Marroquín, A. B., Medina-García, A. C., Vargas Guerrero, A., Barrera-Villalpando, M. I., Martínez-Lavín, M., & Martínez-Martínez, L. A. (2022). Effect of COVID-19 Pandemic Lockdown on Fibromyalgia Symptoms. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 28(1), e289–e291. https://doi.org/10.1097/RHU.0000000000001685
Cavalli, G., Cariddi, A., Ferrari, J., Suzzi, B., Tomelleri, A., Campochiaro, C., De Luca, G., Baldissera, E., & Dagna, L. (2021). Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Rheumatology (Oxford, England), 60(1), 465–467. https://doi.org/10.1093/rheumatology/keaa738
Choy, E., Perrot, S., Leon, T., Kaplan, J., Petersel, D., Ginovker, A., & Kramer, E. (2010). A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC health services research, 10, 102. https://doi.org/10.1186/1472-6963-10-102
Clauw, D. J., Häuser, W., Cohen, S. P., & Fitzcharles, M. A. (2020). Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain, 161(8), 1694–1697. https://doi.org/10.1097/j.pain.0000000000001950
Climent-Sanz, C., Marco-Mitjavila, A., Pastells-Peiró, R., Valenzuela-Pascual, F., Blanco-Blanco, J., & Gea-Sánchez, M. (2020). Patient reported outcome measures of sleep quality in fibromyalgia: a COSMIN systematic review. International journal of environmental research and public health, 17(9), 2992.
Galvez-Sánchez, C. M., Duschek, S., & Reyes Del Paso, G. A. (2019). Psychological impact of fibromyalgia: current perspectives. Psychology research and behavior management, 12, 117–127. https://doi.org/10.2147/PRBM.S178240
Goesling, J., Brummett, C. M., Meraj, T. S., Moser, S. E., Hassett, A. L., & Ditre, J. W. (2015). Associations Between Pain, Current Tobacco Smoking, Depression, and Fibromyalgia Status Among Treatment-Seeking Chronic Pain Patients. Pain medicine (Malden, Mass.), 16(7), 1433–1442. https://doi.org/10.1111/pme.12747]
Haukoos, J. S., & Lewis, R. J. (2005). Advanced statistics: bootstrapping confidence intervals for statistics with "difficult" distributions. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 12(4), 360–365. https://doi.org/10.1197/j.aem.2004.11.018
Lassen, C. L., Siam, L., Degenhart, A., Klier, T. W., Bundscherer, A., & Lindenberg, N. (2021). Short-term impact of the COVID-19 pandemic on patients with a chronic pain disorder. Medicine, 100(10), e25153. https://doi.org/10.1097/MD.0000000000025153
Lisboa, C. P. (2021). Pandemia e aumento da desigualdade de renda no Brasil: Desafios ao SUAS: Pandemic and income inequality increase in Brazil: Challenges to the Unified Social Assistance System (SUAS). Revista Desenvolvimento Social, 27(2), 197-220.
Maffei M. E. (2020). Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. International journal of molecular sciences, 21(21), 7877. https://doi.org/10.3390/ijms21217877.
Mohabbat, A. B., Mohabbat, N. M. L., & Wight, E. C. (2020). Fibromyalgia and Chronic Fatigue Syndrome in the Age of COVID-19. Mayo Clinic proceedings. Innovations, quality & outcomes, 4(6), 764–766. https://doi.org/10.1016/j.mayocpiqo.2020.08.002
MARTINEZ, José Eduardo et al. EpiFibro (Registro Brasileiro de Fibromialgia): dados sobre a classificação do ACR e preenchimento dos critérios diagnósticos preliminares e avaliação de seguimento. Revista Brasileira de Reumatologia, v. 57, p. 129-133, 2017
Salaffi, F., Giorgi, V., Sirotti, S., Bongiovanni, S., Farah, S., Bazzichi, L., Marotto, D., Atzeni, F., Rizzi, M., Batticciotto, A., Lombardi, G., Galli, M., & Sarzi-Puttini, P. (2021). The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome. Clinical and experimental rheumatology, 39 Suppl 130(3), 72–77. https://doi.org/10.55563/clinexprheumatol/dnxtch.
Sauch Valmaña, G., Miró Catalina, Q., & Vidal-Alaball, J. (2022). Prevalence and Incidence of Patients With Fibromyalgia in Catalonia Between 2010 and 2017: A Descriptive Observational Study. Journal of primary care & community health, 13, 21501319221094169. https://doi.org/10.1177/21501319221094169
Siracusa, R., Paola, R. D., Cuzzocrea, S., & Impellizzeri, D. (2021). Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. International journal of molecular sciences, 22(8), 3891. https://doi.org/10.3390/ijms22083891
Verbunt, J. A., Pernot, D. H., & Smeets, R. J. (2008). Disability and quality of life in patients with fibromyalgia. Health and quality of life outcomes, 6, 8. https://doi.org/10.1186/1477-7525-6-8
Wolfe, F., Walitt, B., Perrot, S., Rasker, J. J., & Häuser, W. (2018). Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PloS one, 13(9), e0203755. https://doi.org/10.1371/journal.pone.0203755
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Maria Letícia Carvalho da Cruz Ramos; Luísa Teixeira Silveira; Maria Elisa Sobral Vila Nova de Carvalho Vieira ; Natália Araújo Barreto; Alejandra Debbo; Lucas Augusto Reis Pereira de Oliveira ; Delza Correia Lima; Jefferson Felipe Calazans Batista
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
